MEDICALLY REVIEWED

Gadopiclenol (Elucirem™) for Contrast-Enhanced MRI

MRI
The US FDA granted regulatory approval to Gadopiclenol (Elucirem™), a new macrocyclic GBCA for use in adults and children aged 2 years and older, for contrast-enhanced MRI.

Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

lipids
Lipids: Types and Disorders

Both fats and cholesterol belong to a wider group of chemical molecules called lipids. Lipids are one of the most important substances in our body with many different roles. There

Read More »